|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.880 USD | +25.76% |
|
+10.63% | -57.01% |
| 11/09/25 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 01/04/25 | GRI Bio Prices up to $13 Million Equity Offering | MT |
| Market Cap | 5.39M 4.64M 4.37M 3.99M 7.46M 509M 7.48M 51.59M 20.02M 261M 20.25M 19.81M 842M | P/E 2021 |
-4.2x | P/E 2022 | -0.42x |
|---|---|---|---|---|---|
| Enterprise Value | 1.61M 1.39M 1.31M 1.19M 2.23M 152M 2.24M 15.42M 5.98M 78.09M 6.05M 5.92M 252M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
-
| Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +25.76% | ||
| Current month | -57.01% | ||
| Current year | -57.01% |
| 5 years | 2.33 |  | 310.8 |
| 10 years | 2.33 | | 310.8 |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -9.3M -8.01M -7.53M -6.88M -12.87M -878M -12.91M -89M -34.54M -451M -34.93M -34.17M -1.45B | -7.02M -6.04M -5.69M -5.19M -9.72M -663M -9.74M -67.2M -26.08M -340M -26.38M -25.8M -1.1B |
| Net Debt | -7.34M -6.32M -5.94M -5.43M -10.16M -693M -10.18M -70.23M -27.25M -356M -27.57M -26.96M -1.15B | -3.78M -3.25M -3.06M -2.8M -5.23M -357M -5.25M -36.17M -14.04M -183M -14.2M -13.89M -590M |
Employees
-
Sector
-
| Date | Price | Change |
|---|---|---|
| 04/09/26 | $2.880 | +25.76% |
| 03/09/26 | $2.290 | +14.50% |
| 02/09/26 | $2.000 | +4.71% |
| 01/09/26 | $1.910 | -0.52% |
| 31/08/26 | $1.920 | 0.00% |
- Stock Market
- Stocks
- GRI Stock
Select your edition
All financial news and data tailored to specific country editions
